APOE ε4 is associated with decreased synaptic density in cognitively impaired participants
Authors:
Open Access
- 13 March 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (5) , 3157-3166
Abstract
INTRODUCTION: We aimed to investigate the effect of apolipoprotein E4 (APOE) ε4 on synaptic density in cognitively impaired (CI) participants.METHODS: One hundred ten CI participants underwent amyloid positron emission tomography (PET) with 18F‐florbetapir and synaptic density PET with 18F‐SynVesT‐1. We evaluated the influence of APOE ε4 allele on synaptic density and investigated the effects of ε4 genotype on the associations of synaptic density with Alzheimer's disease (AD) biomarkers. The mediation effects of AD biomarkers on ε4‐associated synaptic density loss were analyzed.RESULTS: Compared with non‐carriers, APOE ε4 allele carriers exhibited significant synaptic loss in the medial temporal lobe. Amyloid beta (Aβ) and tau pathology mediated the effects of APOE ε4 on synaptic density to different extents. The associations between synaptic density and tau pathology were regulated by the APOE ε4 genotype.DISCUSSION: The APOE ε4 allele was associated with decreased synaptic density in CI individuals and may be driven by AD biomarkers.Keywords
Funding Information
- National Key Research and Development Program of China (2016YFC1306305, 2018YFE0203600)
- National Natural Science Foundation of China (81801752, 82171473, 82271441, 82201583)
This publication has 45 references indexed in Scilit:
- Sex Differences in Alzheimer’s Disease: Insights From the Multiomics LandscapeBiological Psychiatry, 2022
- Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET ImagingMolecular Imaging and Biology, 2020
- In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PETAlzheimer's & Dementia, 2020
- Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic ImagingJAMA Neurology, 2018
- Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer DiseaseJAMA Neurology, 2017
- APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's diseaseAlzheimer's & Dementia, 2016
- Meta‐analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerabilityAlzheimer's & Dementia, 2016
- A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRINeuroImage, 2015
- The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s DiseaseNeuron, 2014
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011